1. Emerging Markets in Life Sciences Syrposium:
The Power of Partnershrps
Thursday, July 24,2OL4
L2:OOPM - 4:00PM EST
620 Eighth Avenue #33
Presented By
Center for
- Healthcare
[,rnnovaron

2. The Emerging Markets in Life Sciences Symposium l: The Power of
Partnerships is one of the world's leading annual events focused
specifically on emerging markets of the global life science industry,
including IATAM, China, lndia, Africa, and Eastern Europe and Russia.
The symposium is an interactive, collaborative setting for the world's
leading life science and healthcare executives, entrepreneurs, policy-
makers, researchers, scientists, technologists, academics, and service
providers to exchange best practices and discuss the opportunities and
challenges of emerging life science markets around the globe' The
symposium also explores how partnerships are key to achieving
success in emerging pharmaceutica! markets. Participants will gain
valuable contacts, connections, knowledge, information, and insights.
Dear Symposium Attendees,
On behalf of the Center for Healthcare lnnovation (CHl), we welcome you to the
2nd annual Emerging Markets in Life Sciences Symposium l: The Power of
Partnerships. lt is a privilege to welcome back those who participated in last
year's symposium, as well as greet newcomers to our collaborative discussion.
Our goal for today is to provide an intimate, selective, and collaborative setting
for leading life science and healthcare executives and thought-leaders to
discuss the intersection of the life science industry and emerging markets.
From issues such as the power of partnerships, a rapidly-growing global middle-
class, increased consumer demand, the availability of skilled human capital,
political and governmental structures, the protection of intellectual property and
compliance within the global regulatory framework, and new and attractive
regions for R&D and clinical trials, we hope today's symposium provides a
collaborative setting to discuss the challenges, opportunities, and best practices
surrounding the life science industry in emerging markets.
We would like to thank all of today's supporters, including our host, Seyfarth
Shaw, our Co-promotion partners, and all our distinguished moderators and
panelists. Finally, we would like to thank you all for joining today's discussion.
We wish you an informative and productive afternoon, and hope you enjoy
today's discussion surrounding emerging markets in the life sciences.
Kindest Regards,
Symposium Planning Committee
Center for Healthcare lnnovation

3. PRESEITTED BY
Center for Healthcare Innovation (CHI)
CHI is a 501(c)(3), non-profit research center committed to excellence
and innovation in the global life sciences industries, primarily the
biotech, medical device, and pharmaceutical sectors. We aim to be
the world's #1 source of rigorous, objective thought-leadership and
innovative solutions for the international life science ecosystem.
20 14Supporters
F{$ST
SEYFARTHArroR''r Eys'SFf,W;
Breacith. Depiir. Results.
PR.O}{ OTIO N PART}TER*S
p ruvu lnnrs & scrENcE
Center for Bioethics; Life, Health & Environment
I NYCNew York City Economic Development Corporation
ffirifl{rx"$tM*
Center for
- Healthcare
Or rnnovaron
Ob:ective Research. [ffect]ve Solutions.
lailn

4. S+"Jr"A- k*. tl'{ q
yiu kl ?i'*nt
Registration, Lunch, & Networki.g l2:00- l2:55
Opening Remarks l2:55- l:00
. Mr.Joff Masukawa, SpecialAdvisor; Center for Healthcare lnnovation; Vice President and Global
Head, Government Relations and Public Affairs, Shire
. Mr. Brent Schneider, Strategic Development Lead, Center for Healthcare lnnovation
Strategy & New Market Entry Panel Discussion l:00- l:50
. Mr. Raymond Arroyo, Board Member; National Hispanic MedicalAssociation; Secretary & Chairman .
:S':::*:.?:::.:',?,::x,':';11',:tH!l1T,T::l--t:::::*g?,*:'ffi$"ffiY^1'ff^x:,fr'*"{u D* Pramod Gaur, Vice Chair; AmericanTelemedicineAssociation Wth^q?n#.['#;,}
{ . F1* Rick Henrig, CIO PartnenTatum; Executive Director, Health lT, Bristol-MyerrSquibb (forme}) "
-i . Mr. Rick Henrig, CIO Partnerfatum; Executive Director; Health lI BrlstoljMyeSquibb (fon
**r. Mr:Anthony Romagnole, Managing Partner; CVt Consulting; Senior Director, Pfir (former);-
Managing Partner,CVl Consulting - Yr'&.1 ofhrxrza-G;tntrBrt llqrtarJ,-f BS r^ [^7*,*-,
. Dn Bratislav Stankovic, ChaiG Strategic Planning and Transition Committee, Public
I ntellectual Property Advisors vru ErLsVN E{lrr*Ls
hhr{ tto./H- l^rq rlwt{-
t, "ol
gnf ' z !"Ot_U"atr^l*s;
Reseorch & DeveloPment and Alliances Panel D iscu ssion
"foo:/5ii'"
. Ma Esteban "Steve" Ferrer, Partner; Sey'arth Shaw (Moderator)
. DnJohn Doyle, SeniorVice President and Managing Directori Global MarketAccess &
Cgmmgrgi_alization.-Qujntiles;Assistant Professo[ Columbia University :
. Ml:ft.Xtititiit'ul6t, bl5biivice President,Alliance Management, Covance 6*J,,*.,ol, otqriz{
^eass
. Mn Alan Polonsky, Global Directo[ Sourcing,Thermo Fisher Scientific
. Mr. Deva Puranam, Global Director of Quality, Regulatory, Compliance, and New Product
Development,Thermo llbgr Scientific *a caururt,.o bivl,os s" ),*.^tw""{
Morketing & Business DeveloPment Panel Discussion 3:00-3:50
. Mr, Laurence Birch, Chairman & Chief Executive Officer, Datatrak (Moderator)
. Dr. OmarAlvarez-Pousa, Director; BusinessTechnology,Zoetls (formerly PfizerAnimal Health);
Adiunct Professori NYU
. Mr. Craig Delarge, Global Leaden Multichannel Marketing Strategy & lnnovation, Merck (former)
. Mr,Angel lriz4rry, Senigr Qlrggtog Supportive- Care; U.S. Oncology Marketing, Easai
. ryrrylE*zffiffilrtg,*6#e';g#i'S;fiAh3i-y.fi{81fih" ,.as or$l i' 6nd* 1*$.^n ** $",yafl
. iffJeremieTrochu, Head of Global Marketlng & Strategy, Catalent Pharma Sotutions
. Mr.AlanVanderborght, Founder and Principal,Torreya-EM; CEq Lucas Pharma
Closing Remarks 3:50-4:00
. Mn Dennis Urbaniak, Chairman of Executive Council, Center for Healthcare lnnovation; Managing
Directo[ Accenture

5. Registration, Lunch, & Networking l2:00- l2:55
Opening Remarks I2:55- !:00
. Mr.foff Masukawa, SpecialAdvisor; Center for Healthcare lnnovation; Vice President and Global
Head, Government Relations and Public Affairs, Shire
. Mr. Brent Schneider, Strategic Development Lead, Center for Healthcare lnnovation
Strate gy & New Morket Entry Pane! Discussion I :00- I :50
Mr. Raymond Arroyo, Board Member, National Hispanic MedicalAssociation;Secretary & Chairman
Elect of the Board of Directors, U.S. Hispanic Chamber of Commerce (Moderator)
Dr. Pramod Gaur, Vice Chair, American Telemedicine Association
Mr. Rick Herwig, CIO Partner,Tatum; Executive Director, Health lT, Bristol-Myers Squibb (former)
Mr.Anthony Romagnole, Managing Partner, CVI Consulting;Senior Directori Pfizer (former);
Managing Partneri CVI Consulting
Dr. Bratislav Stankovic, Chair, Strategic Planning and Transition Commitree, Public lnterest
I ntel lectual Property Advisors
Reseorch & Development and Allionces Panel Discussion 2:00-2:50
a
a
Mr. Esteban "Steve" Ferrer, Partne6 Seyfarth Shaw (Moderator)
Mr.fos6 Oct6vio Costa Filho, GCTO PMO / Clinical Development for Emerging Markets, Merck
DaJohn Doyle, SeniorVice President and Managing Directori Global MarketAccess &
Com me rcial ization, Qu i nti I es; Ass istant Professo r, Co I u m bia U n iversity
Ms. Katie Margules, Global Vice President,Alliance Management, Covance
Dr. Luis Rios-Nogales, Head, Global Development Delivery,Takeda Vaccines
Morketing & Business Development Panel Discussion 3:00-3:50
. Mr. Laurence Birch, Chairman & Chief Executive Officer, Datatrak (Moderator)
. Dr. Branimir Brankov, Head of Emerging Markets Business Development, Merck
. Mr. Craig DeLarge, Global Leader; Multichannel Marketing Strategy & lnnovation, Merck (former)
. Mr.Angel lrizarry, Senior Directo6 Supportive Care; U.S. Oncology Marketing, Easai
. Mr.feremieTrochu, Head of Global Marketing & Strategy, Catalent Pharma Solutions
. Mr. Alan Vanderborght, Founder and Principal,Torreya-EM; CEq Lucas Pharma
Closing Remarks 3:50-4:00
. Mr. Dennis Urbaniak, Chairman of Executive Council, Center for Healthcare lnnovation; Managing
Directoti Accenture

6. Accenture
Allscripts
American Telemedici ne Association
Baxter lnternational
BD
Biogen ldec
Catalent Pharma Solutions
Center for Healthcare !nnovation
Columbia Business School
Columbia University
Covance
CVI Consulting
Datatrak
Eisai
!nformation Management Network (lMN)
LatinTRENDS
Lucas Pharma
Merck
National Hispanic Life Sciences Society
National Hispanic Medical Association
New York City Economic Development Corporation
Novartis
NYU
NYU Center for Bioethics
Pfizer
Princeton University
Public Interest lntellectual Property Advisors
Quintiles
Seyfarth Shaw
Shire
Takeda Vaccines
Tatum
The Feinstein lnstitute of North Shore-LlJ Health
System
Torreya-Emerg ing Markets
U.S. Hispanic Chamber of Commerce
Women !n Healthcare & Life Sciences

7. I Committed to Excellence $
'!l V 2OlS lYlNXEn r[
V f nr^so,snrcu,suro V
g+rr PEERAWARDSd.I9
lnnovative Law Firm of the Year
Received the top two awards for excellence
in innovation and t{hnology used by law
fims prsmted bythe lnttrnational Legal
Technology Assciation (ILTA).
lnnovation Leader
R<ognized as the top-ranking
fim to r innovation to deliEr
legal sflice aligned with client
reeds based m corporate counsel
fedback f rom the world's larg6t
companis.
Client Service Elite Honors
For the third conscutive year, S€yfarth was
named to BTI Consulting's Client Seruice
30 list, which represents the "cream of tle
crop" of law firms on client service.
@se*ACC Value Champion
RKognized as an ACC Val€
Champion fs our innovative
collaboratim with a clbnt lo
manage its outsurcing of
contracts.
h*j@>
Most Innovative
AEr(bd to Lt#ging Panntr
Stephs P€r for h6 instumental
rde in the creation and evoluton
of the fim's client *Mce model,
5 eyfarthlean.
Fi*ancral IImes
{,rS /nnoyafive Lavuyers Report
tinancial Times US Law
Firm lnnovator
Seyfarth earned a spot among the FfUs
lnnovative Lawyers 2013 index of tlE m6t
innovative firms, including top-ranking
honors in the Business of Law.
lnnovAction Awards
Recognized for "outstanding
innovation in the delivery of legal
-rvics" by the College of Law
Practice Management (COLPM).
p r.rvu lenrs & scrENcE
Center for Bioethics: Life, Health & Environment
NYC..New York City Economic Development Corporation
ff$im"lxtMJ
a
lANNIRTilII$
Special thanks to past sponsors and supporters
of previous events, conferences, and symposia
ffi Microsoft
Katten ,.r..tt1fOI
DnrerRAK
I BDO Pharggg$icar
lTiflder
II'TERHTLL EIATASTTE'
X Smart. Simpte, Serure,

8. Center for
- Healthcare
[. lnnovation
.@'''"'_
The World's Leading Think Tank for the Global Life Science Ecosystem
.. - ":*'
'.=-:
Obiecrve Research. Efective Soiutic:s
Healthcare
WhoWeAre
An organization comprised of accomplished and talented individuals from a rich array of backgrounds, cultures, and experiences:
GLOBAL COUNC'L
o Dr. Bavaguthu Raghuram Shetty, Founder, Managing Director & CEO, NMC Group
. Dr. Bandi Parthasaradhi Reddy, Founder, Chairman, CEO, & Managing Director, Hetero Group
o Dr. Anita Goel, Founder, Chairman, & Scientific Director, Nanobiosym; Chairman & CEO, Nanobiosym Diagnostics
BOARD OF D'RECTORS
o Mr. Michel J. Feldman (Chairman), Partner, Sey'arth Shaw; Founding Board Member, Watson Pharmaceuticals
r Dr. Nelson L. Levy (Vice Chairman), Chairman & CEO, CoreTechs Corporation
o Dr. Samir Bhattacharyya, World Wide Director of Market Access, Depuy Mitek, a Johnson & Johnson Company
o Dr. fames J. Gillespie, Chief Executive Offlcer & Co-Founder, Center for Healthcare lnnovation
o Mr. Sanjay Kadaveru, Co-Founder, Center for Healthcare lnnovation
o Dr. Linda McAllister, Chief Medical Officer & Vice President of R&D, PharmaJet
. Dr. Andrea Small-Howard, President, lnternational Biotechnology Solutions
EXECUTIYE COUNC'I
o Mr. Dennis Urbaniak (Chairman), Managing Director, Accenture
o Dr. Laurent Audoly (Vice Chairman), Senior Vice President, Research & Development, Fabre Laboratories
o Ms. foanna Brougher, Senior Council, Vaccinex
. Mr. Lewis Feldberg, Chief Executive Officer, Esteve USA (former)
o Dr. Albert Jaramillo, Vice President, Human Resources, Global R&D, Pfizer (retired)
o Mr. Michael Ndmoli, Vice President Life Sciences, Solution Management, SAP Labs (former)
r Ms. f ulie Sawyer-Montgomery, Vice President, Global Medication Management Systems & Business Insights, Hospira
r Mr. Richard Smith, Managing Director, Life Sciences & Specialty Services, FedEx Express
o Dr. Eckhard von Keutz, Senior Vice Presideng Head Global Early Development, Bayer HealthCare
STRATEGY GROUP
o Mr. James Jordan (Chairman), Distinguished Service Professor in Healthcare & Biotechnology Managemeng Carnegie Mellon University
o Mr. Mark Kwatia (Vice Chairman), Diagnostics Assay Design, Abbott Laboratories
o Dr. G. Randall Green, Founder, Secant Therapeutics
o Dr. Marco Quarta, Director, lnstitute for Bioengineering in Stem Cell & Regenerative Medicine, Stanford University
o Dr. Kate Rosenbluth, Biodesign lnnovation Fellow, Stanford University
o Dr. James Su, Senior Research Engineer, Abbott Vascular
SPECIAL ADY'SORS
o Mr. Mark Hattas, Founder, Former CEO, & Chairman, Geneca
o Mr. Joff Masukawa, Vice President and Global Head, Government Relations and Public Affairs
e Dr. Stuart Rich, Professor of Medicine, University of Chicago
C.^,':;;;,t. ii-. I,S;- ia-:;e r *', :-",2: -:; ,'i':. info@chisite.orq chisite.oro
ffi fiE f,I *-

9. Upcoming Events
Unintended Consequences of Healthcare & Life Science Legislation
A symposium for leading life science and healthcare executives, entrepreneurs, policymakers, researchers, scientists,
technologists, academics, and service providers to collaborate in a non-paftisan forum for discussing the unintended
consequences of healthcare and life science legislation in the U.S. and around the worlfo
Wednesday, October I5, 2014
Washington, D.C., USA
ch isite.org/events/Legislation
lnnovative Partnerships in Healthcare Executive Roundtable
An invitation-only, executive roundtable discussion for senior healthcare and life science executives to discuss
partnerships, collaboration, and innovation among the key stakeholders of the 2lst Century healthcare syste1,
Thursday, October, 6, 20 I 4
ch isite.org/events/i n novative Partn e rsh i ps
Emerging Markets in Life Sciences Symposium ll:The Role of Relationships
One of the world's leading annual events focused specifically on emerging markets of the global life science industry,
including LATAM, China, lndia, Africa, and Eastern Europe and Russia. The symposium is an interactive, collaborative
setting for the world's leading life science and healthcare executives to exchange best practices and discuss the
opportunities and challenges of emerging life science markets around the globe. The symposium explores how
relationships are key to achieving success in emerging pharmaceutical markets. Participants will gain valuable
contacts, connections, knowledge, information, and insights.
Thursday, October 23, 20 I 4
San Francisco, CA, USA
ch isite.org/events/em ergi ngMarketsRelationsh i ps
Diversity, lnclusion, & Life Sciences Symposium
An interactive and collaborative symposium for life sciences and healthcare executives to discuss best practices as
well as challenges and opportunities at the crucial interface of diversity, inclusion, and the life sciences industry.
Participants will gain valuable contacts, connections, knowledge, information, and insights $
Wednesday, June I0, 2015
Chicago, lL USA
I ifesciencesd iversity.org
Priscilla Espinosa
Visiting:32nd Floor
Seyfarth Shaw LLP
The New York Times Building
07-24-2014
i$+F